Iga Swiatek's doping controversy refuses to die down. The post Tennis Controversy: Iga Swiatek’s Doping Drama Highlights Double Standards as Frustrated Insider Minces No Words appeared first on EssentiallySports.

The five-time Grand Slam champion has served 22 days of a one-month ban from tennis. Here's what you need to know

Iga Swiatek is the second high-profile tennis player to test positive for a banned substance this year, joining Jannik Sinner. While Sinner, currently the No. 1 ranked man, was fully cleared, Swiatek,

Meanwhile, Swiatek was found to have been “at the lowest end of the range for no significant fault or negligence” after the 23-year-old Polish player explained that her doping violation was caused by a contaminated supply of the non-prescription medication melatonin, which she uses to help with jet lag and sleep issues.

Swiatek said she couldn't play over the fall owing to 'personal matters'. That didn't really explain what was going on

The topic of doping is back in the world of tennis this year. The first case that shocked fans around the world was that of Jannik Sinner, who tested positive for Clostebol in two different controls in March (during the Indian Wells Masters 1000).

The International Tennis Integrity Agency says five-time Grand Slam champion Iga Swiatek has accepted a one-month suspension after testing positive for the banned substance trimetazidine.

While superstar players Iga Swiatek and Jannik Sinner were able to quickly and quietly explain away their positive test results, players further down the rankings are complaining about unfair treatmen

World number two Iga Swiatek has accepted a one-month suspension after testing positive for the prohibited substance trimetazidine (TMZ).

Iga Swiatek, the No. 2 ranked women's tennis player in the world, has accepted a one-month suspension for violating the Tennis Anti-Doping Program, the International Tennis Integrity Agency announced on Thursday.